Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer-Reference-Cited by-同舟云学术

Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer

Published:2016-07 Issue:1 Volume:120 Page:76-80
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Rasmussen Jacob H.^ORCID,Håkansson Katrin,Vogelius Ivan R.,Aznar Marianne C.,Fischer Barbara M.,Friborg Jeppe,Loft Annika,Kristensen Claus A.,Bentzen Søren M.,Specht Lena

Funder

Arvid Nilssons Foundation

NCI

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference23 articles.

1. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial;Overgaard;Lancet Oncol,2010

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study;Nordsmark;Radiother Oncol,2005

4. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake;Due;Radiother Oncol,2014

5. Optimal dose distribution for eradication of heterogeneous tumors;Brahme;Acta Oncol,1987

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics for clinical decision support in radiation oncology;Clinical Oncology;2024-08

2. A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE);Radiotherapy and Oncology;2024-07

3. Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin;Radiotherapy and Oncology;2024-07

4. Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery;Physics and Imaging in Radiation Oncology;2024-07

5. Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma;Clinical and Translational Radiation Oncology;2024-01